Sterile Egg Global Market Report 2025

The sterile egg market size has grown strongly in recent years. It will grow from $1.47 billion in 2024 to $1.59 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth during the historic period can be attributed to the increasing reliance on embryonated eggs for influenza strain cultivation, the rising government-funded research on zoonotic disease prevention, the growing demand for sterile substrates in veterinary vaccine development, the increasing use of sterile eggs in toxicology testing, and the rising interest in alternative protein expression platforms using eggs.

The sterile egg market size is expected to see strong growth in the next few years. It will grow to $2.15 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth during the forecast period can be attributed to the increasing use of sterile eggs in vaccine production, the rising demand from biopharmaceutical companies, the growing research and development activities in life sciences, the increasing adoption of sterile eggs for diagnostic applications, and the rising prevalence of infectious diseases driving vaccine manufacturing. Key trends in the forecast period include advancements in egg-based vaccine production technologies, enhanced biosecurity measures in sterile egg farming, innovations in automated egg sterilization processes, the integration of sterile eggs in next-generation biopharmaceutical development, and progress in genetic engineering for pathogen-free egg production.

The rising food safety concerns are expected to drive the growth of the sterile egg market in the coming years. Food safety concerns refer to potential risks from food contamination, adulteration, or poor hygiene that can pose health hazards to consumers. These concerns are increasing due to the growing use of chemical additives and pesticides in food production, which raises the risk of harmful residues entering the food chain and impacting consumer health. Sterile eggs help address these concerns by eliminating harmful bacteria such as Salmonella through sterilization, providing safer egg-based ingredients for food products and reducing the risk of foodborne illnesses. For example, in October 2024, according to the World Health Organization (WHO), a Switzerland-based UN agency coordinating international public health responses, an estimated 600 million people, nearly one in ten globally, fall ill each year from contaminated food, resulting in approximately 420,000 deaths annually. Therefore, the growing food safety concerns are contributing to the expansion of the sterile egg market.

Key companies operating in the sterile egg market are focusing on innovations such as specific pathogen free (SPF) poultry bio-manufacturing units to enhance disease-free egg production, ensure food safety, and meet the rising demand from pharmaceutical and high-quality food sectors. An SPF poultry bio-manufacturing unit is a facility that produces eggs and poultry free from specific pathogens, ensuring high biosecurity and quality for pharmaceutical and food applications. For instance, in November 2024, Medion AG, a Germany-based consumer electronics company, established Indonesia’s first SPF egg production facility to supply high-quality, disease-free eggs for food and pharmaceutical use. The facility supports national health and biosecurity, reduces import dependency, ensures consistent vaccine inputs, and drives scientific innovation for both animal and human health sectors.

In January 2025, Ba Huân Corporation, a Vietnam-based food company, partnered with Sanovo Technology Group to advance automated egg processing and improve production efficiency. This partnership aims to deliver high-quality, food-safe liquid egg products that meet diverse customer needs while enhancing operational efficiency, food safety, and overall production excellence, positioning Ba Huân as a leader in Vietnam’s egg processing industry. Sanovo Technology Group is a Denmark-based company specializing in egg handling and processing technology.

Major players in the sterile egg market are Cargill Incorporated, Cal-Maine Foods Inc., Michael Foods Inc., Rose Acre Farms Inc., Noble Foods Ltd, Pete & Gerry's Organic Eggs Inc., Ovostar Union, Wilcox Farms Inc., Wabash Valley Produce Inc., Rembrandt Foods LP, Farm Pride Pty Ltd, Deb-El Foods Inc., Eggs Unlimited Inc., Igreca S.A.S., Batory Foods Inc., Willamette Egg Farms Inc., Global Food Group LLC, Crystal Lake LLC, Hickman's Family Farms LLC, Pulviver S.P.R.L.

North America was the largest region in the sterile egg market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sterile egg report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the sterile egg market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The accelerated imposition of U.S. tariffs and the emerging trade conflicts in spring 2025 are significantly influencing the food and beverage sector by raising the costs for imported ingredients including olive oil, cheese, and tropical fruits, forcing food brands to reformulate products or accept lower margins. Beverage makers face similar pressures, with aluminum can tariffs increasing packaging expenses. Retaliatory tariffs on U.S. agricultural exports (e.g., soybeans, pork) have also disrupted farm-to-processing supply chains. Companies are reformulating recipes, sourcing locally where possible, and hedging commodity purchases to manage volatility.

The sterile egg market research report is one of a series of new reports that provides sterile egg market statistics, including sterile egg industry global market size, regional shares, competitors with a sterile egg market share, detailed sterile egg market segments, market trends and opportunities, and any further data you may need to thrive in the sterile egg industry. This sterile egg market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Sterile eggs refer to eggs that have been sterilized to eliminate all microorganisms, including bacteria, viruses, and fungi, making them safe for use in laboratory, pharmaceutical, and vaccine production applications. These eggs are produced under controlled, pathogen-free conditions to ensure sterility, particularly for embryonated egg-based vaccine manufacturing (such as influenza vaccines) and biotechnological research.

The key types of sterile eggs are egg yolk, egg white, and whole egg. Egg yolk is the nutrient-rich yellow portion of the egg, containing fats, vitamins, and proteins. Sterile eggs are available in various forms, including liquid, powdered, frozen, dried, and others, and are distributed through online retail, offline retail, direct sales, distributors, and wholesalers. Applications span the food industry, pharmaceuticals, cosmetics, nutraceuticals, and animal feed, serving end users such as hospitals, diagnostic centers, research institutes, and others.

The sterile egg market consists of sales of sterile embryonated eggs, sterile liquid egg products, and pathogen-free eggs. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.